News
April 17, 2018
Sarah Boyce Joins Akcea Therapeutics as President and Member of the Board of DirectorsApril 9, 2018
Ionis and AstraZeneca Advance New Drug for NASHFollow us on 
Spotlight
Ionis Pharmaceuticals Publishes Paper on Growth of RNA-targeted Therapeutics in Cell Metabolism
More »
IONIS NEURO-TTR Phase 3 Clinical Trial Highlighted at American College of Cardiology (ACC) Annual Meeting
More »
FDA Accepts Plazomicin’s NDA with Priority Review for the Treatment of Complicated Urinary Tract Infections and Bloodstream Infections
More »
Ionis’ SPINRAZA Recognized with Prestigious Prix Galien Award for Best Biotechnology Product
More »
Clinical Trials
We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »
